Cilcare SAS
Cilcare SAS
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study Testing Safety and Efficacy of Transtympanic Paliroden for the Treatment of Cochlear Synaptopathy in Participants With Chronic, Constant Tinnitus | Cochlear Synaptopathy, Ear Diseases, Hearing Loss, Hidden, Neurologic Manifestations, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, hearing disorder, hearing loss disorder, nervous system disorder, otorhinolaryngologic disease, tinnitus | Not yet recruiting | Phase 1 / Phase 2 | 2026-09-17 | NCT07826507 | |
| A Study Testing the Safety and Possible Benefits of an Ear Injection of a New Compound, Paliroden, in People With Type 2 Diabetes Who Have Difficulty Understanding Speech in Noisy Situations | Cochlear Synaptopathy, Ear Diseases, Hearing Loss, Hidden, Neurologic Manifestations, Nutritional and Metabolic Diseases, Pathological Conditions, Signs and Symptoms, Sensation Disorders, Signs and Symptoms, diabetes mellitus, endocrine system disorder, glucose metabolism disease, hearing disorder, hearing loss disorder, metabolic disease, nervous system disorder, otorhinolaryngologic disease | Not yet recruiting | Phase 1 / Phase 2 | 2026-03-16 | NCT07472907 | |
| Early Stage of Alzheimer's and Parkinson's Diseases, HearIng Relevance (SAPHIR) | Cognition Disorders, Cognitive Dysfunction, Parkinson disease, basal ganglia disorder, brain disorder, central nervous system disorder, cognitive disorder, movement disorder, nervous system disorder, neurodegenerative disease, parkinsonian disorder, psychiatric disorder, synucleinopathy | Recruiting | Not applicable | 2025-12-09 | NCT07083089 |